| abstract |
SUMMARY OF THE INVENTION The present invention relates to the use of compounds that inhibit the activity or activation of metabotropic glutamate receptors for use in the treatment of movement disorders associated with lack of movement (such as Parkinson's disease). The compounds are particularly useful when used in combination with other therapeutic agents and, surprisingly, reduce the extent and incidence of side effects (such as dyskinesia) associated with such therapeutic agents. |